Company Filing History:
16 out of 3,397 
1 out of 2 Years Active: 2013-2026
Title: Donna McEachern: Innovator in BET Protein Degradation
Introduction
Donna McEachern is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds targeting BET bromodomains. With a total of 17 patents to her name, her work is paving the way for innovative treatments for various cancers.
Latest Patents
Among her latest patents, McEachern has developed compounds such as "Fused 1,4-oxazepines as BET protein degraders." This patent provides compounds represented by Formula I, which are designed to treat conditions responsive to the degradation of BET bromodomains, including cancer. Another notable patent is "BET bromodomain protein degraders with cleavable linkers," which also focuses on compounds for treating disorders related to the inhibition and degradation of BET bromodomains.
Career Highlights
Throughout her career, McEachern has worked with esteemed institutions, including the University of Michigan and Jiangsu Ascentage Biomed Development Inc. Her research has significantly advanced the understanding and treatment of cancer through innovative chemical compounds.
Collaborations
McEachern has collaborated with notable colleagues such as Shaomeng Wang and Liu Liu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Donna McEachern's work exemplifies the impact of innovative research in the field of medicinal chemistry. Her contributions to the development of BET protein degraders are crucial in the fight against cancer, showcasing her dedication to advancing medical science.